Literature DB >> 22733460

Maternal cardiovascular impairment in pregnancies complicated by severe fetal growth restriction.

Karen Melchiorre1, George Ross Sutherland, Marco Liberati, Basky Thilaganathan.   

Abstract

Fetal growth restriction and preeclampsia are both conditions of placental etiology and associated to increased risk for the long-term development of cardiovascular disease in the mother. At presentation, preeclampsia is associated with maternal global diastolic dysfunction, which is determined, at least in part, by increased afterload and myocardial stiffness. The aim of this study is to test the hypothesis that women with normotensive fetal growth-restricted pregnancies also exhibit global diastolic dysfunction. This was a prospective case-control study conducted over a 3-year period involving 29 preterm fetal growth-restricted pregnancies, 25 preeclamptic with fetal growth restriction pregnancies, and 58 matched control pregnancies. Women were assessed by conventional echocardiography and tissue Doppler imaging at diagnosis of the complication and followed-up at 12 weeks postpartum. Fetal growth-restricted pregnancies are characterized by a lower cardiac index and higher total vascular resistance index than expected for gestation. Compared with controls, fetal growth-restricted pregnancy was associated with significantly increased prevalence (P<0.001) of asymptomatic left ventricular diastolic dysfunction (28% versus 4%) and widespread impaired myocardial relaxation (59% versus 21%). Unlike preeclampsia, cardiac geometry and intrinsic myocardial contractility were preserved in fetal growth-restricted pregnancy. Fetal growth-restricted pregnancies are characterized by a low output, high resistance circulatory state, as well as a higher prevalence of asymptomatic global diastolic dysfunction and poor cardiac reserve. These findings may explain the increased long-term cardiovascular risk in these women who have had fetal growth-restricted pregnancies. Further studies are needed to clarify the postnatal natural history of cardiac dysfunction in these women.

Entities:  

Mesh:

Year:  2012        PMID: 22733460     DOI: 10.1161/HYPERTENSIONAHA.112.194159

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  N-cadherin knockdown leads to disruption of trophoblastic and endothelial cell interaction in a 3D cell culture model - New insights in trophoblast invasion failure.

Authors:  A Multhaup; B Huppertz; C Göhner; M Böhringer; M Mai; U Markert; E Schleußner; T Groten
Journal:  Cell Adh Migr       Date:  2017-12-12       Impact factor: 3.405

2.  Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy.

Authors:  Laura Benschop; Sarah Schalekamp-Timmermans; Zoe A Broere-Brown; Jeanine E Roeters van Lennep; Vincent W V Jaddoe; Jolien W Roos-Hesselink; M Kamran Ikram; Eric A P Steegers; James M Roberts; Robin E Gandley
Journal:  Circulation       Date:  2019-04-02       Impact factor: 29.690

Review 3.  Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review.

Authors:  Leslie Cho; Melinda Davis; Islam Elgendy; Kelly Epps; Kathryn J Lindley; Puja K Mehta; Erin D Michos; Margo Minissian; Carl Pepine; Viola Vaccarino; Annabelle Santos Volgman
Journal:  J Am Coll Cardiol       Date:  2020-05-26       Impact factor: 24.094

4.  Ambulatory Blood Pressure Trajectory and Perceived Stress in Relation to Birth Outcomes in Healthy Pregnant Adolescents.

Authors:  Julie Spicer; Gerald F Giesbrecht; Sally Aboelela; Seonjoo Lee; Grace Liu; Catherine Monk
Journal:  Psychosom Med       Date:  2019-06       Impact factor: 4.312

5.  Pregnancy Complications and Later Development of Hypertension.

Authors:  Suttira Intapad; Barbara T Alexander
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-06-01

Review 6.  Hypertension in pregnancy: natural history and treatment options.

Authors:  L Foo; J Tay; C C Lees; C M McEniery; I B Wilkinson
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

7.  Endothelial cell dysfunction and cardiac hypertrophy in the STOX1 model of preeclampsia.

Authors:  Aurélien Ducat; Ludivine Doridot; Rosamaria Calicchio; Celine Méhats; Jean-Luc Vilotte; Johann Castille; Sandrine Barbaux; Betty Couderc; Sébastien Jacques; Franck Letourneur; Christophe Buffat; Fabien Le Grand; Paul Laissue; Francisco Miralles; Daniel Vaiman
Journal:  Sci Rep       Date:  2016-01-13       Impact factor: 4.379

Review 8.  Relevance of Haemodynamics in Treating Pre-eclampsia.

Authors:  Christoph Lees; Enrico Ferrazzi
Journal:  Curr Hypertens Rep       Date:  2017-08-23       Impact factor: 5.369

9.  Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats.

Authors:  Hannah L Morgan; Elaine Butler; Shona Ritchie; Florian Herse; Ralf Dechend; Elisabeth Beattie; Martin W McBride; Delyth Graham
Journal:  Hypertension       Date:  2018-05-29       Impact factor: 10.190

Review 10.  Echocardiographic Techniques of Deformation Imaging in the Evaluation of Maternal Cardiovascular System in Patients with Complicated Pregnancies.

Authors:  Silvia Visentin; Chiara Palermo; Martina Camerin; Luciano Daliento; Denisa Muraru; Erich Cosmi; Luigi P Badano
Journal:  Biomed Res Int       Date:  2017-08-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.